Form 8-K - Current report:
SEC Accession No. 0000353569-19-000058
Filing Date
2019-10-30
Accepted
2019-10-30 16:15:30
Documents
16
Period of Report
2019-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-201909308xk.htm   iXBRL 8-K 53671
2 EXHIBIT 99.1 qdel-20190930exhibit991.htm EX-99.1 348409
8 qdel8k20image1a17.jpg GRAPHIC 11058
  Complete submission text file 0000353569-19-000058.txt   589779

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20191030.xsd EX-101.SCH 4660
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20191030_cal.xml EX-101.CAL 697
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20191030_def.xml EX-101.DEF 1547
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20191030_lab.xml EX-101.LAB 27263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20191030_pre.xml EX-101.PRE 14187
12 EXTRACTED XBRL INSTANCE DOCUMENT qdel-201909308xk_htm.xml XML 4703
Mailing Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 191180270
SIC: 2835 In Vitro & In Vivo Diagnostic Substances